ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Callisto Pharmaceuticals,

Callisto Pharmaceuticals, (KAL)

0.00
0.00
(0.00%)
Cerrado 07 Diciembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

KAL Últimas noticias

Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal -

Callisto Pharmaceuticals, Inc. (AMEX: KAL), announced today that on April 7, 2008, it received notice from the American Stock Exchange indicating that AMEX intends to strike the...

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

Callisto Pharmaceuticals, Inc. Receives Notice From AMEX

NEW YORK, June 22 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (AMEX:KAL), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
UAMYUnited States Antimony Corp
US$ 1.895
(40.37%)
20.28M
GPUSHyperscale Data Inc
US$ 6.79
(36.35%)
647.91k
CHROChannel Therapeutics Corporation
US$ 0.8349
(26.31%)
1.09M
ROLRHigh Roller Technologies Inc
US$ 6.60
(16.40%)
29.63k
DSSDSS Inc
US$ 1.04
(12.95%)
93.24k
CTMCastellum Inc
US$ 0.28675
(-18.07%)
6.51M
PWPower REIT
US$ 1.90
(-16.30%)
1.06M
UMACUnusual Machines Inc
US$ 8.66
(-15.51%)
4.17M
UAVSAgEagle Aerial Systems Inc
US$ 5.735
(-14.40%)
1.82M
SCPXScorpius Holdings Inc
US$ 0.3978
(-13.75%)
515.71k
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 0.9556
(-4.11%)
614.58M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 29.61
(1.68%)
49.15M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3.165
(3.77%)
39.96M
SPYSPDR S&P 500
US$ 607.81
(0.19%)
30.8M
TZADirexion Daily Small Cap Bear 3X Share New
US$ 10.485
(-1.08%)
30.58M
wallstreet1231 wallstreet1231 9 minutos hace
It would seem more plausible to believe the programs are dead if there is nothing to update in 6-12 months plus. If so, just state they are dead or shelved. If not, update where the projects stand. Agree.

Many penny stocks go into long periods of silence and do a lot of business b
SNPW
1hot toddy 1hot toddy 13 minutos hace
BILLION $ co is merging with smx. huge money with smx. they have product whole world needs with no competion. new partner is a billion $ company and ceo wants life changing products and SMX got it.
SMX
marcis marcis 13 minutos hace
Here is some new DD.

Rather than talk about dilution ( adding to the OS) which was small compared to the notes selling off, the value and size of the company, along with the company’s management history and structure is what forward investors look at.

A little more on O
RDAR
rayovac812 rayovac812 17 minutos hace
Amazing how hard the crooked Wall Street players work to try and kill AVXL. Peer review and EMA acceptance are on the crooks radar. Hit pieces are lying in wait.

Institutional buyers are counting on those crooks, to do what they do. There are several possibilities for whoever is
AVXL
1hot toddy 1hot toddy 19 minutos hace
SMX IS GOING TO BE THE PARTNER OF YBYRA.$$$. monster money is on smx. ybyra has the money, smx has the world wide product that whole world needs. hmbl gets almost nothing and they got billions of shares. smx got very little.
too many people got 3s and 4s and 5s. i made 6x and im out and in bi
SMX
Nebuchadnezzar Nebuchadnezzar 23 minutos hace
BOTY its time for a run to 0025+

https://www.stockscores.com/chart.asp?TickerSymbol=BOTY&TimeRange=365&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=100&avgType2=SMA&movAvg2=150&Indicator1=AccDist&I
BOTY
GrandAdmiralThrawn GrandAdmiralThrawn 25 minutos hace
Well I guess I'll see you next week.
rx7171 rx7171 26 minutos hace
These presentations usually aren’t to show failed trial data.
AVXL
PonderosaPack PonderosaPack 30 minutos hace
got it
IONQ
rx7171 rx7171 31 minutos hace
Requesting AA at the submittal and saying so, but then not being granted could be read by the market as a negative.
It would maybe be more strategic to request on the submittal but not make public then if granted make a PR to that effect. Market would like that.
AVXL
Milesblue42 Milesblue42 31 minutos hace
Trading Granny, is RonnFord a ConArtist??

Please share with us how you heard about Ronn. Are you loading up for a quick trade? Do you have confidence in the company? Your enthusiasm is encouraging but it would be helpful to know what it’s based on or you might get labeled a pumper. We
RONN
Dark_Lord Dark_Lord 32 minutos hace
Did it go through?
PMPG
gdog gdog 32 minutos hace
oklo was $27.00 smr $29.00 and I had them both on watch, I just watch to many and miss some real nice plays.
NLST
GoldRu$$H GoldRu$$H 32 minutos hace
Not seeing a recent parade of others at SMR dumping, so perhaps she was just an outlier inside trade. I'm guessing her interim VP tag may soon be lifted and if she moves to VP; the salary bump and stock options will fill the gap created by her current depleted holdings of 3,801 shares.
SMR
leverage102 leverage102 33 minutos hace
The Attorney Filing reply motion in opposition to receivers report;

Jawad I Fitter, Attorney, The Founding Member of Fitter Law LLC.

Looking forward $$$

GLTA!!

Blessings
NSAV
Milesblue42 Milesblue42 35 minutos hace
Still Holding? Basher Index sounded Incredibly Stupid...

Page 6 had the information from the Company about how things are unfolding now IMO.

Page 6 makes and made the alleged Basher Index sound beyond Idiotic.....
RONN
HomeRunSwing HomeRunSwing 35 minutos hace
So does DEFTF 👍️
DEFTF
bigstocksnbonds bigstocksnbonds 35 minutos hace
That's A LOT LOT OF HOURS CONGRATS!!!!!!!!!!!
PonderosaPack PonderosaPack 37 minutos hace
Kona - If I am reading you correctly - you are stating that these statements are to protect IonQ? I believe this verbiage is for that purpose.
IONQ
TRAPPER JIM TRAPPER JIM 38 minutos hace
I got 58 1/2 hours in this week. I got almost 14 today 
konshe konshe 41 minutos hace
If news out, PPS jump to 1$ possible
RDGL
HoldEm777 HoldEm777 47 minutos hace
Sorry bro…. Droopysack is a real doober. 😉
SFIO
lodas lodas 49 minutos hace
It is patently obvious that you are scraping the "bottom" to intellectualize your reasons to substantiate recovery of your assets, however, I would welcome a movie about my life experiences.... it could be written like this:..... era depression lad rises through travails of post WW11 economic adjus
COOP
Konaploinks Konaploinks 50 minutos hace
Every shareholder needs to read the 8 k that I copied and pasted a few posts back. . Take it point by point. There must be some , maybe many buyout offers being submitted imo This is probably just the first of a few 8 k’s to set up a poison pill for any hostile takeover etc. The next should be about
IONQ

Su Consulta Reciente

Delayed Upgrade Clock